TMO(TMO)
TMO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $47.77B | $50.35B | $53.51B | $56.47B | $58.18B |
| Low | $46.74B | $48.85B | $53.47B | $55.44B | $57.13B |
| High | $48.04B | $51.03B | $53.54B | $56.97B | $58.70B |
| EBITDA Avg | $13.04B | $13.74B | $14.61B | $15.41B | $15.88B |
| Low | $12.76B | $13.33B | $14.60B | $15.13B | $15.59B |
| High | $13.11B | $13.93B | $14.62B | $15.55B | $16.02B |
| EBIT Avg | $9.64B | $10.16B | $10.80B | $11.40B | $11.74B |
| Low | $9.43B | $9.86B | $10.79B | $11.19B | $11.53B |
| High | $9.70B | $10.30B | $10.81B | $11.50B | $11.85B |
| Net Income Avg | $9.36B | $10.21B | $11.17B | $12.74B | $14.24B |
| Low | $9.29B | $9.90B | $10.22B | $12.44B | $13.91B |
| High | $9.43B | $10.52B | $12.11B | $12.88B | $14.41B |
| EPS Avg | $24.86 | $27.19 | $30.03 | $33.78 | $37.78 |
| Low | $24.64 | $26.26 | $27.11 | $32.98 | $36.89 |
| High | $25.02 | $27.90 | $32.13 | $34.17 | $38.22 |
| Analysts (Rev / EPS) | 19 / 15 | 19 / 15 | 16 / 5 | 15 / 1 | 15 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $11.71B | $11.97B | $13.11B | $11.76B | $12.28B | $12.55B | $13.72B | $12.57B |
| Low | $11.38B | $11.72B | $12.90B | $11.57B | $12.08B | $12.35B | $13.50B | $12.37B |
| High | $11.88B | $12.06B | $13.25B | $11.87B | $12.40B | $12.67B | $13.86B | $12.70B |
| EBITDA Avg | $3.20B | $3.27B | $3.58B | $3.21B | $3.35B | $3.43B | $3.75B | $3.43B |
| Low | $3.11B | $3.20B | $3.52B | $3.16B | $3.30B | $3.37B | $3.69B | $3.38B |
| High | $3.24B | $3.29B | $3.62B | $3.24B | $3.38B | $3.46B | $3.78B | $3.47B |
| EBIT Avg | $2.36B | $2.42B | $2.65B | $2.37B | $2.48B | $2.53B | $2.77B | $2.54B |
| Low | $2.30B | $2.37B | $2.60B | $2.33B | $2.44B | $2.49B | $2.72B | $2.50B |
| High | $2.40B | $2.43B | $2.67B | $2.40B | $2.50B | $2.56B | $2.80B | $2.56B |
| Net Income Avg | $2.13B | $2.38B | $2.74B | $2.22B | $2.37B | $2.59B | $2.95B | $2.51B |
| Low | $2.10B | $2.28B | $2.68B | $2.18B | $2.32B | $2.54B | $2.89B | $2.46B |
| High | $2.23B | $2.41B | $2.77B | $2.25B | $2.40B | $2.63B | $2.99B | $2.54B |
| EPS Avg | $5.72 | $6.37 | $7.34 | $5.96 | $6.35 | $6.95 | $7.91 | $6.73 |
| Low | $5.63 | $6.11 | $7.19 | $5.84 | $6.22 | $6.80 | $7.75 | $6.59 |
| High | $5.97 | $6.46 | $7.44 | $6.04 | $6.43 | $7.04 | $8.02 | $6.82 |
| Analysts (Rev / EPS) | 13 / 15 | 13 / 15 | 6 / 7 | 6 / 6 | 6 / 6 | 6 / 6 | 6 / 6 | 5 / 13 |